Telescoping perfusion management system

• US 20070282260A1
• Filed: 08/09/2007
• Published: 12/06/2007
• Est. Priority Date: 04/19/2004
• Status: Active Grant

• Current Assignee: Gearbox LLC (Intellectual Ventures LLC)
• Original Assignee: Searete LLC (Intellectual Ventures LLC)
• Inventors: Wood, Lowell
• Granted Patent: US 8,361,014 B2
• Time in Patent Office: Days
• US Class Current: 604/118
• CPC Class Codes: A61B 2017/00991 Telescopic means
• CPC Class Codes: A61K 31/19 Carboxylic acids, e.g. valproic acid salicylic acid A61K31/60
• CPC Class Codes: A61M 2205/3523 using telemetric means
• CPC Class Codes: A61M 2205/52 with memories providing a history of measured variating parameters of apparatus or patient
• CPC Class Codes: A61M 5/14276 specially adapted for implantation
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00

Abstract

A system for perfusion management that monitors, maintains, diagnoses, or treats perfusion deficiencies.

Claims

1-41. -41. (canceled)

42-80. -80. (canceled)

81. A method for perfusion management, comprising:

storing a receivable in a cavity;

extending a tractable conduit between the cavity and a location in an animal; and

delivering the receivable to the location in the animal.

82. The method of claim 81, wherein the method further comprises:

guiding, positioning, and/or directing the tractable conduit for traveling the interior of a blood vessel.

83. The method of claim 81, wherein the method further comprises:

charging a polymer to make a wave motion and move contents of the tractable conduit and/or the cavity.

84. The method of claim 81, wherein the method further comprises:

charging a polymer to perform an action.

85. The method of claim 81, wherein the method comprises:

imaging, and/or detecting a level of pressure, temperature, chemical, gas, electrolyte, composition, concentration, and/or flow.

86. The method of claim 81, wherein the method further comprises:

delivering chemicals, chemical compounds, proteins, lipoproteins, glycoproteins, sugars, lipids, antigens, antibodies, cytokines, peptides, neurotransmitters, hormones, ions, messenger molecules, nucleic acids, engineered nucleic acids, nucleic acid vectors, drugs, cells, cell fragments, cell organelles, liposomes, pharmaceutical agents, biological materials, and/or biological fractions in proximity to the location in the animal.

87. The method of claim 81, wherein the method further comprises:

performing one or more operations and/or actions.

88. The method of claim 81, wherein the method further comprises:

positioning tools in the animal.

89. The method of claim 81, wherein the method further comprises:

fully or partially blocking and/or shunting a liquid flow.

90. The method of claim 81, wherein the method further comprises:

ablating, degrading, and/or liquefying a cell, a mass of cells, a tissue, and/or an assembly of biological materials exhibiting shear strength.

91. The method of claim 81, wherein the method further comprises:

capturing a cell, a tissue, a fluid, a gel, a sample, a colloid, an emulsion, a debris, a contaminant, and/or a biological material.

92. The method of claim 81, wherein the method further comprises:

sampling a cell, a mass of cells, a tissue, and/or an assembly of biological materials exhibiting shear strength.

93. The method of claim 81, wherein the method further comprises:

cauterizing and/or sealing a cell, a mass of cells, a tissue, and/or an assembly of biological materials exhibiting shear strength.

94. The method of claim 81, wherein the method further comprises:

dispensing a fluid at a controlled rate.

95. The method according to claim 81, wherein the method further comprises:

controlling and/or guiding the tractable conduit.

96. The method according to claim 81, wherein the method further comprises:

configuring the device for perfusion management for placing in the animal wherein the animal is a human.

97. The method according to claim 96, wherein the method further comprises:

configuring the device for perfusion management for placing in a new location in the human.

98. The method according to claim 81, wherein the method further comprises:

configuring the device for perfusion management for placing in a circulatory system, an aorta, in a vena cava and/or in a nervous system.

99. The method according to claim 81, wherein the method further comprises:

releasing an electric current and/or an electromagnetic radiation in proximity to a cell, a tissue, and/or an assembly of biological materials exhibiting shear strength.